Invention Grant
- Patent Title: Nucleoside phosphate compound and preparation method and use thereof
-
Application No.: US16344317Application Date: 2017-12-19
-
Publication No.: US10899786B2Publication Date: 2021-01-26
- Inventor: Jiaqiang Cai , Shuai Song , Qiang Tian , Yitao Zhang , Haitao Huang , Guoqing Zhong , Wei Zhong , Yongjia Hao , Mingliang Zhao , Hong Zeng , Hongmei Song , Xin Zhou , Yao Liu , Yuting Tan , Lichun Wang , Jingyi Wang
- Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
- Applicant Address: CN Chengdu
- Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
- Current Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Chengdu
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: CN201611204909 20161223,CN201710059345 20170124,CN201710991293 20171023
- International Application: PCT/CN2017/117126 WO 20171219
- International Announcement: WO2018/113652 WO 20180628
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; C07H19/10 ; A61P1/16 ; C07H1/02
Abstract:
Provided in the present invention are a compound of Formula (I), a pharmaceutical composition comprising the same, a method for preparing the same, and use thereof as a NS5B polymerase inhibitor, a DNA polymerase inhibitor or a reverse transcriptase inhibitor for the prevention or treatment of viral diseases or cancers.
Public/Granted literature
- US20200308214A1 NUCLEOSIDE PHOSPHATE COMPOUND AND PREPARATION METHOD AND USE THEREOF Public/Granted day:2020-10-01
Information query
IPC分类:
